A. B. Gottlieb, “Long-term Safety of Secukinumab Over Five Years in Patients with Moderate-to-severe Plaque Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis: Update on Integrated Pooled Clinical Trial and Post-marketing Surveillance Data”, Acta Derm Venereol, vol. 102, p. adv00698, Apr. 2022.